ResMed Inc. Changes Auditor; Director Ronald Taylor to Retire

What Happened

• ResMed filed an 8-K on August 17, 2026, reporting that KPMG LLP was dismissed as the company’s independent registered public accounting firm effective August 13, 2026. KPMG's audit reports for the fiscal years ended June 30, 2026 and 2025 were unmodified and contained no adverse opinions, disclaimers, qualifications, disagreements, or reportable events.
• The Audit Committee selected PricewaterhouseCoopers LLP (PwC) on August 13, 2026 to serve as ResMed’s independent registered public accounting firm for the fiscal year ending June 30, 2027, subject to PwC’s standard client acceptance procedures. The company states it did not consult PwC on accounting or auditing matters during the prior two fiscal years or the interim period through August 13, 2026.
• Also on August 13, 2026, director Ronald Taylor informed the Board he will not stand for re-election and intends to retire at ResMed’s 2026 annual meeting of stockholders (expected November 18, 2026). The Board approved appointing Carol Burt as lead director effective November 15, 2026. A press release announcing these items was furnished on August 17, 2026.

Key Details

• KPMG dismissal effective: August 13, 2026.
• PwC appointment approved by Audit Committee: August 13, 2026; subject to PwC client acceptance.
• Director retirement: Ronald Taylor to retire at the annual meeting expected November 18, 2026.
• New lead director: Carol Burt to become lead director effective November 15, 2026.
• Exhibits filed: KPMG’s letter to the SEC (Exhibit 16.1) and the company press release (Exhibit 99.1), both dated August 17, 2026.

Why It Matters

• Auditor change is material to investors because it affects who audits ResMed’s financial statements going forward. The filing notes KPMG’s prior reports were unmodified and no disagreements were reported, which reduces immediate concerns about prior-period audits. Nevertheless, PwC’s acceptance and future audit opinions are items to watch in upcoming filings.
• The planned retirement of a director and the appointment of a new lead director signal a change in board leadership and governance. These are governance events that can influence investor views on oversight but do not by themselves indicate changes to operations or financial performance.